Palantir’s Earnings Divide: Wall Street Can’t Agree on the Price, but the Numbers Speak for Themselves

Palantir reports Q1 earnings amid a $140 gap between bull and bear price targets, with revenue expected to jump 74% and insider selling topping $137 million.

The gap between Palantir’s operational momentum and its stock price has rarely been wider. As the company prepares to report first-quarter results after the US market close today, the shares are trading at €125.08 — roughly 30% below their November 2025 peak and down over 12% since the start of the year. The disconnect is fueling one of the most polarized analyst debates in the AI sector.

A $140 chasm between bull and bear cases

The range of price targets is extraordinary even by the standards of high-growth tech. Wedbush’s Dan Ives remains the most bullish voice on the Street, sticking with a $230 target and describing Palantir as a potential trillion-dollar enterprise. At the opposite end, RBC Capital Markets has slapped a sell rating on the stock and values it at just $90. Analyst Rishi Jaluria has flagged concerns about customer attrition.

The split deepened in the run-up to earnings. Oppenheimer upgraded the stock to buy with a $200 target, praising the stickiness of Palantir’s software platform. HSBC, meanwhile, downgraded to hold, pointing to intensifying competition. The median target across 21 analysts sits at $194.06, implying upside of roughly 36% from current levels. Fourteen analysts recommend buying, but the dissenters are making themselves heard.

The numbers that matter

Wall Street expects revenue of $1.54 billion for the first quarter, a 74% jump from a year ago. Earnings per share are pegged at $0.28 — more than double the prior-year quarter. Palantir has beaten consensus estimates for ten consecutive quarters, and any break in that streak would send alarm bells ringing.

Two metrics will draw the most scrutiny. Commercial revenue is forecast at around $771 million, growth of over 94% and significantly outpacing the government segment. The annual guidance is equally critical: analysts are watching for an upgrade to the current forecast of roughly $7.19 billion, powered by the AIP platform’s accelerating adoption.

The government side offers structural tailwinds. The Pentagon’s budget draft earmarks $2.3 billion specifically for Palantir’s Maven Smart System, and a separate $300 million contract with the USDA strengthens revenue visibility. But the commercial engine is where the story gets interesting — and where the valuation debate gets heated.

Valuation: the elephant in the room

Even after the pullback, Palantir trades at roughly 94 times forward earnings — down from nearly double that at the start of the year, but still eye-watering by any historical standard. The stock has shed around 20% since January, and the options market is pricing in a swing of roughly 10% in either direction following tonight’s release.

Insiders have been taking advantage of the elevated price levels. Over the past 90 days, executives sold shares worth more than $137 million. CEO Alexander Karp alone offloaded roughly $66 million worth of stock. There have been zero insider purchases during that period — a detail that hasn’t gone unnoticed by skeptics.

What comes next

The immediate catalyst is tonight’s print, but the real test is the full-year outlook. If Palantir raises its 2026 guidance, the stock could challenge key resistance at $146.30. A miss or a cautious tone would accelerate the downtrend that has already erased a third of the company’s market value from its peak.

The broader context matters too. Palantir is reporting into a tech earnings season defined by stark contrasts. Chipmakers like Samsung and Intel are riding physical scarcity — chips simply can’t be made fast enough to meet demand. Software companies, by contrast, must sell narratives of future growth against a backdrop of stretched multiples and concentration risk. Palantir’s challenge is to prove that its commercial acceleration is durable enough to justify a price that still assumes perfection.